• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of biochemjBJ Latest papers and much more!
Biochem J. May 1, 2002; 363(Pt 3): 761–768.
PMCID: PMC1222529

Inhibition of cell growth through inactivation of eukaryotic translation initiation factor 5A (eIF5A) by deoxyspergualin.

Abstract

The mechanism of inhibition of cell growth by deoxyspergualin was studied using mouse mammary carcinoma FM3A cells. Results of studies using deoxyspergualin analogues showed that both the guanidinoheptanate amide and glyoxyspermidine moieties of deoxyspergualin were necessary to cause inhibition of cell growth. When deoxyspergualin was added to the medium, there was a strong inhibition of cell growth and formation of active eukaryotic translation initiation factor 5A (eIF5A) at the third day of culture. There was also a marked decrease in cellular putrescine content and a small decrease in spermidine content. Accumulation of decapped mRNA, which is typically associated with eIF5A deficiency in yeast, was also observed. The inhibition of cell growth and the formation of active eIF5A was not reversed by addition of spermidine. The activity of deoxyhypusine synthase, the first enzyme in the formation of active eIF5A, was inhibited by deoxyspergualin in a cell-free system. These results, taken together, indicate that inhibition of active eIF5A formation is strongly involved in the inhibition of cell growth by deoxyspergualin.

Full Text

The Full Text of this article is available as a PDF (195K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Umezawa H, Kondo S, Iinuma H, Kunimoto S, Ikeda Y, Iwasawa H, Ikeda D, Takeuchi T. Structure of an antitumor antibiotic, spergualin. J Antibiot (Tokyo) 1981 Dec;34(12):1622–1624. [PubMed]
  • Umeda Y, Moriguchi M, Kuroda H, Nakamura T, Iinuma H, Takeuchi T, Umezawa H. Synthesis and antitumor activity of spergualin analogues. I. Chemical modification of 7-guanidino-3-hydroxyacyl moiety. J Antibiot (Tokyo) 1985 Jul;38(7):886–898. [PubMed]
  • Plowman J, Harrison SD, Jr, Trader MW, Griswold DP, Jr, Chadwick M, McComish MF, Silveira DM, Zaharko D. Preclinical antitumor activity and pharmacological properties of deoxyspergualin. Cancer Res. 1987 Feb 1;47(3):685–689. [PubMed]
  • Umezawa H, Ishizuka M, Takeuchi T, Abe F, Nemoto K, Shibuya K, Nakamura T. Suppression of tissue graft rejection by spergualin. J Antibiot (Tokyo) 1985 Feb;38(2):283–284. [PubMed]
  • Makino M, Fujiwara M, Watanabe H, Aoyagi T, Umezawa H. Immunosuppressive activities of deoxyspergualin. II. The effect on the antibody responses. Immunopharmacology. 1987 Oct-Nov;14(2):115–121. [PubMed]
  • Pai LH, FitzGerald DJ, Tepper M, Schacter B, Spitalny G, Pastan I. Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice. Cancer Res. 1990 Dec 15;50(24):7750–7753. [PubMed]
  • Nadler SG, Tepper MA, Schacter B, Mazzucco CE. Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science. 1992 Oct 16;258(5081):484–486. [PubMed]
  • Tepper MA, Nadler SG, Esselstyn JM, Sterbenz KG. Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation. J Immunol. 1995 Sep 1;155(5):2427–2436. [PubMed]
  • Fujihara SM, Nadler SG. Modulation of nuclear protein import: a novel means of regulating gene expression. Biochem Pharmacol. 1998 Jul 15;56(2):157–161. [PubMed]
  • Umeda Y, Moriguchi M, Kuroda H, Nakamura T, Fujii A, Iinuma H, Takeuchi T, Umezawa H. Synthesis and antitumor activity of spergualin analogues. II. Chemical modification of the spermidine moiety. J Antibiot (Tokyo) 1987 Sep;40(9):1303–1315. [PubMed]
  • Hibasami H, Tsukada T, Suzuki R, Takano K, Takaji S, Takeuchi T, Shirakawa S, Murata T, Nakashima K. 15-Deoxyspergualin, an antiproliferative agent for human and mouse leukemia cells shows inhibitory effects on the synthetic pathway of polyamines. Anticancer Res. 1991 Jan-Feb;11(1):325–330. [PubMed]
  • Schnier J, Schwelberger HG, Smit-McBride Z, Kang HA, Hershey JW. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Mol Cell Biol. 1991 Jun;11(6):3105–3114. [PMC free article] [PubMed]
  • Magdolen V, Klier H, Wöhl T, Klink F, Hirt H, Hauber J, Lottspeich F. The function of the hypusine-containing proteins of yeast and other eukaryotes is well conserved. Mol Gen Genet. 1994 Sep 28;244(6):646–652. [PubMed]
  • Jakus J, Wolff EC, Park MH, Folk JE. Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines. J Biol Chem. 1993 Jun 25;268(18):13151–13159. [PubMed]
  • Park MH, Wolff EC, Folk JE. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors. 1993 May;4(2):95–104. [PubMed]
  • Ayusawa D, Iwata K, Seno T. Alteration of ribonucleotide reductase in aphidicolin-resistant mutants of mouse FM3A cells with associated resistance to arabinosyladenine and arabinosylcytosine. Somatic Cell Genet. 1981 Jan;7(1):27–42. [PubMed]
  • Seyfried CE, Morris DR. Methods for the study of the physiological effects of inhibitors of polyamine biosynthesis in mitogen-activated lymphocytes. Methods Enzymol. 1983;94:373–389. [PubMed]
  • Maeda K, Umeda Y, Saino T. Synthesis and background chemistry of 15-deoxyspergualin. Ann N Y Acad Sci. 1993 Jun 23;685:123–135. [PubMed]
  • Igarashi K, Kashiwagi K, Hamasaki H, Miura A, Kakegawa T, Hirose S, Matsuzaki S. Formation of a compensatory polyamine by Escherichia coli polyamine-requiring mutants during growth in the absence of polyamines. J Bacteriol. 1986 Apr;166(1):128–134. [PMC free article] [PubMed]
  • Fujii S, Hitomi Y. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta. 1981 Oct 13;661(2):342–345. [PubMed]
  • Kakinuma Y, Sakamaki Y, Ito K, Cragoe EJ, Jr, Igarashi K. Relationship among activation of the Na+/H+ antiporter, ornithine decarboxylase induction, and DNA synthesis. Arch Biochem Biophys. 1987 Nov 15;259(1):171–178. [PubMed]
  • Matsui I, Pegg AE. Effect of thioacetamide, growth hormone or partial hepatectomy on spermidine acetylase activity of rat liver cytosol. Biochim Biophys Acta. 1980 Nov 17;633(1):87–94. [PubMed]
  • He Y, Kashiwagi K, Fukuchi J, Terao K, Shirahata A, Igarashi K. Correlation between the inhibition of cell growth by accumulated polyamines and the decrease of magnesium and ATP. Eur J Biochem. 1993 Oct 1;217(1):89–96. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Kameji T, Hayashi S, Hoshino K, Kakinuma Y, Igarashi K. Multiple regulation of ornithine decarboxylase in enzyme-overproducing cells. Biochem J. 1993 Jan 15;289(Pt 2):581–586. [PMC free article] [PubMed]
  • Suzuki T, Sadakata Y, Kashiwagi K, Hoshino K, Kakinuma Y, Shirahata A, Igarashi K. Overproduction of S-adenosylmethionine decarboxylase in ethylglyoxal-bis(guanylhydrazone)-resistant mouse FM3A cells. Eur J Biochem. 1993 Jul 15;215(2):247–253. [PubMed]
  • Smit-McBride Z, Dever TE, Hershey JW, Merrick WC. Sequence determination and cDNA cloning of eukaryotic initiation factor 4D, the hypusine-containing protein. J Biol Chem. 1989 Jan 25;264(3):1578–1583. [PubMed]
  • Kim KK, Yokota H, Kim R, Kim SH. Cloning, expression, and crystallization of a hyperthermophilic protein that is homologous to the eukaryotic translation initiation factor, eIF5A. Protein Sci. 1997 Oct;6(10):2268–2270. [PMC free article] [PubMed]
  • Igarashi K, Terada K, Tango Y, Katakura K, Hirose S. Demonstration by affinity chromatography of the cell-free synthesis of ribonuclease-specific immunoglobulin. J Biochem. 1975 Feb;77(2):383–390. [PubMed]
  • He Y, Suzuki T, Kashiwagi K, Kusama-Eguchi K, Shirahata A, Igarashi K. Correlation between the inhibition of cell growth by bis(ethyl)polyamine analogues and the decrease in the function of mitochondria. Eur J Biochem. 1994 Apr 1;221(1):391–398. [PubMed]
  • Nielsen PJ, Manchester KL, Towbin H, Gordon J, Thomas G. The phosphorylation of ribosomal protein S6 in rat tissues following cycloheximide injection, in diabetes, and after denervation of diaphragm. A simple immunological determination of the extent of S6 phosphorylation on protein blots. J Biol Chem. 1982 Oct 25;257(20):12316–12321. [PubMed]
  • SHORE PA, COHN VH., Jr Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase. Biochem Pharmacol. 1960 Oct;5:91–95. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Laskey RA, Mills AD. Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem. 1975 Aug 15;56(2):335–341. [PubMed]
  • Beppu T, Shirahata A, Samejima K. Determination of covalently bound hypusine and deoxyhypusine to protein using submilligram of protein samples by HPLC. Biol Pharm Bull. 1996 Jan;19(1):1–5. [PubMed]
  • Igarashi K, Saisho T, Yuguchi M, Kashiwagi K. Molecular mechanism of polyamine stimulation of the synthesis of oligopeptide-binding protein. J Biol Chem. 1997 Feb 14;272(7):4058–4064. [PubMed]
  • Joe YA, Wolff EC, Park MH. Cloning and expression of human deoxyhypusine synthase cDNA. Structure-function studies with the recombinant enzyme and mutant proteins. J Biol Chem. 1995 Sep 22;270(38):22386–22392. [PubMed]
  • Fujii H, Takada T, Nemoto K, Abe F, Takeuchi T. Stability and immunosuppressive activity of deoxyspergualin in comparison with deoxymethylspergualin. Transplant Proc. 1989 Jun;21(3):3471–3473. [PubMed]
  • Hiratsuka M, Kuramochi H, Takahashi K, Takeuchi T, Oshimura M. Cytostatic effect of deoxyspergualin on a murine leukemia cell line L1210. Jpn J Cancer Res. 1991 Oct;82(10):1065–1068. [PubMed]
  • Pera PJ, Kramer DL, Sufrin JR, Porter CW. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. Cancer Res. 1986 Mar;46(3):1148–1154. [PubMed]
  • He Y, Suzuki T, Kashiwagi K, Igarashi K. Antizyme delays the restoration by spermine of growth of polyamine-deficient cells through its negative regulation of polyamine transport. Biochem Biophys Res Commun. 1994 Aug 30;203(1):608–614. [PubMed]
  • Zuk D, Jacobson A. A single amino acid substitution in yeast eIF-5A results in mRNA stabilization. EMBO J. 1998 May 15;17(10):2914–2925. [PMC free article] [PubMed]
  • Park MH, Wolff EC, Lee YB, Folk JE. Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J Biol Chem. 1994 Nov 11;269(45):27827–27832. [PubMed]
  • Veress I, Haghighi S, Pulkka A, Pajunen A. Changes in gene expression in response to polyamine depletion indicates selective stabilization of mRNAs. Biochem J. 2000 Feb 15;346(Pt 1):185–191. [PMC free article] [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • Gene (nucleotide)
    Gene (nucleotide)
    Records in Gene identified from shared sequence links
  • MedGen
    MedGen
    Related information in MedGen
  • Nucleotide
    Nucleotide
    Published Nucleotide sequences
  • Protein
    Protein
    Published protein sequences
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...